Uses of Saviorli

Saviorli drug is manufactured in hard capsule form, used in combination with a low calorie diet in the treatment of obese patients, preventing weight gain in patients with a mass index above 30... To To ensure the effectiveness of use when using Saviorli, users need to follow the instructions of their doctors, and refer to more information about the uses of Saviorli in the following article.

1.1. What is Saviorli? Saviorli belongs to the group of gastrointestinal drugs, with registration number VD-23012-15, manufactured by SaVi pharmaceutical joint stock company.
Saviorli drug includes the following ingredients:
Main active ingredient: Orlistat in the form of 50% granules equivalent to Orlistat 120mg. Empty cyst number 1: 1 cyst. Excipients of microparticles: talcum powder, starch, microcrystalline cellulose, sodium starch glycolate, povidone K30 and titanium dioxide. The drug is prepared in the form of hard capsules of 120mg, packed in blisters of 10 tablets, each box of 5 blisters.
Saviorli is recommended for use in children 12 years of age and older and adults.
1.2. What does Saviorli do? The active ingredient Orlistat in Saviorli with the mechanism of action of undigested triglycerides is not absorbed, resulting in a calorie deficit, effective in weight control. At the recommended therapeutic dose of 120 mg three times a day, Orlistat inhibits approximately 30% of the absorption of fat in food.
Saviorli is prescribed by doctors for use in the following cases:
In combination with a restricted or slightly reduced calorie diet in the treatment of obesity and prevention of weight gain in patients with body mass index (BMI) ≥ 30 kg/m2 or in overweight patients (BMI ≥ 28 kg/m2) Saviorli helps to promote effective long-term weight gain control (causes patients to lose weight, maintain weight and prevent weight gain). Treatment helps patients improve their risk factors and at the same time limit obesity-related diseases, including hypercholesterolemia, non-insulin dependent diabetes, hyperinsulinemia, impaired glucose tolerance, high blood pressure and reduced visceral fat. The safety and effectiveness of using the drug for more than 4 years have not been evaluated.
Contraindications:
Contraindicated to use Saviorli in case:
Patients are allergic to the main ingredient Orlistat or any of the excipients listed above of Saviorli. Children under 12 years old. Patients with chronic malabsorption syndrome or cholestasis.

2.1. How to take Saviorli medicine Saviorli is taken orally. Patients should take the drug with water immediately before, during meals or 1 hour after each main meal. If you miss a meal of the day or have a fat-free meal, you do not need to take orlistat. Doses more than 3 times/day did not increase the benefit. If after 12 weeks of treatment with orlistat the patient is unable to lose weight, consult a doctor or pharmacist. If necessary, treatment can be discontinued and re-tested. 2.2. Dosage of the drug Saviorli Treatment of obesity and prevention of weight gain in adults and adolescents 12 years of age and older: 120mg x 3 times/day with each main fat meal. Overweight people from 18 years old: 60mg x 3 times/day in each meal containing fat. Elderly, patients with hepatic or renal impairment: No dose adjustment is required. Note: Based on measurement of fecal fat, the effects of Orlistat are still seen 24-48 hours after ingestion. After stopping treatment, fecal fat will usually return to pre-treatment levels in 48 to 72 hours.
Handling missed dose:
If you forget to take a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and take your next dose at the scheduled time. Never take twice the dose of Saviorli prescribed. Treatment of overdose:
With a single dose of 800mg Saviorli and multiple doses of up to 400mg x 3 times/day for 15 consecutive days tested on volunteers with normal body weight. Both normal and obese people did not see significant side effects. In the event of an orlistat overdose, the patient should be carefully monitored for 24 hours. Systemic effects related to the lipase inhibitory properties of orlistat should be rapidly reversible.

Diet and regular exercise are important factors in determining the effectiveness of a weight loss program. It is recommended that patients begin a program of diet and exercise prior to initiating treatment with Saviorli. Patients need to maintain a nutritionally balanced and slightly reduced calorie diet, which should contain only about 30% of calories from fat. Should evenly distribute the daily amount of carbohydrates, fats and proteins into 3 main meals. The therapeutic benefits of Saviorli (including weight management and improvement of risk factors) continue with long-term treatment. It is important that patients follow a light, low-fat diet. Food should have a variety of fruits and vegetables. Continue to maintain your diet and exercise program after stopping treatment with Saviorli. Orlistat is used with caution in patients with a history of hyperoxaluria or calcium oxalate stones in the kidney. Dosage adjustment of hypoglycemic agents is required in patients with type 2 diabetes because of improved metabolic control following weight loss in these patients. Supplementation of fat-soluble vitamins may be necessary during long-term treatment, but should be taken at least 2 hours before or after orlistat or at bedtime. The effectiveness of hormonal contraceptives may be reduced in cases where orlistat causes severe diarrhea and patients should be advised to use an additional method of contraception. The use of orlistat during pregnancy is not recommended due to insufficient clinical data. Orlistat should not be administered to a nursing woman because it is not known whether orlistat is distributed into breast milk. Orlistat has no influence on the ability to drive or use machines.

Common side effects during orlistat treatment especially when there is a lot of fat in the meal that have been reported as gastrointestinal disturbances include: Feeling of urgency to urinate and uncontrollable bowel movements, bloating and greasy stools. Other effects include anxiety, headache, fatigue, rectal bleeding, and menstrual irregularities (rare).

The shelf life of Saviorli is 24 months from the date of manufacture. Store Saviorli in a cool, dry place, at a temperature not exceeding 30°C, in the original packaging and protected from light, away from acidic environments. Keep Saviorli out of reach of children. Above is all information about Saviorli drug, patients need to carefully read the instructions for use, consult a doctor / pharmacist before using. Absolutely do not arbitrarily buy Saviorli medicine at home because there may be unwanted side effects.